sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT04033432 · UNKNOWN

Trial details

NCT number: NCT04033432
Sponsor: Northwestern University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents Metastatic Prostate Adenocarcinoma Progressive Disease Prostate Carcinoma Metastatic in the Bone Prostate Carcinoma Metastatic in the Soft Tissue PSA Progression Stage IVB Prostate Cancer AJCC v8 Testosterone Less Than 50 ng/dL

Start date: 2019-09-20
Primary completion: 2021-02-05
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.